Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?

Detalles Bibliográficos
Autores principales: Prasad, Rajendra, Singh, Abhijeet, Gupta, Nikhil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tuberculosis Association of India. Published by Elsevier B.V. 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221684/
https://www.ncbi.nlm.nih.gov/pubmed/36460365
http://dx.doi.org/10.1016/j.ijtb.2022.06.006
_version_ 1784732682934026240
author Prasad, Rajendra
Singh, Abhijeet
Gupta, Nikhil
author_facet Prasad, Rajendra
Singh, Abhijeet
Gupta, Nikhil
author_sort Prasad, Rajendra
collection PubMed
description
format Online
Article
Text
id pubmed-9221684
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Tuberculosis Association of India. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-92216842022-06-24 Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era? Prasad, Rajendra Singh, Abhijeet Gupta, Nikhil Indian J Tuberc Editorial Tuberculosis Association of India. Published by Elsevier B.V. 2022-10 2022-06-23 /pmc/articles/PMC9221684/ /pubmed/36460365 http://dx.doi.org/10.1016/j.ijtb.2022.06.006 Text en © 2022 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Editorial
Prasad, Rajendra
Singh, Abhijeet
Gupta, Nikhil
Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
title Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
title_full Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
title_fullStr Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
title_full_unstemmed Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
title_short Can Pan-TB shorter regimens be a promising hope for ending TB in India by 2025 in ongoing COVID-19 era?
title_sort can pan-tb shorter regimens be a promising hope for ending tb in india by 2025 in ongoing covid-19 era?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221684/
https://www.ncbi.nlm.nih.gov/pubmed/36460365
http://dx.doi.org/10.1016/j.ijtb.2022.06.006
work_keys_str_mv AT prasadrajendra canpantbshorterregimensbeapromisinghopeforendingtbinindiaby2025inongoingcovid19era
AT singhabhijeet canpantbshorterregimensbeapromisinghopeforendingtbinindiaby2025inongoingcovid19era
AT guptanikhil canpantbshorterregimensbeapromisinghopeforendingtbinindiaby2025inongoingcovid19era

Ejemplares similares